Ads
related to: clinical diagnostics companies stock predictions history pricelp.stockstotrade.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Quest Diagnostics (NYSE:DGX), a leader in diagnostic testing and information services, released its fourth quarter results on Jan. 30. The company reported a notable quarter with adjusted earnings ...
SomaLogic, Inc. is a protein biomarker discovery and clinical diagnostics company [1] located in Boulder, Colorado.It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2] The company was acquired by Standard BioTools in January 2024 in an all-stock deal.
The efficient market hypothesis posits that stock prices are a function of information and rational expectations, and that newly revealed information about a company's prospects is almost immediately reflected in the current stock price. This would imply that all publicly known information about a company, which obviously includes its price ...
The company went public in 2000. [6] The initial public offering was June 21, 2000 at US$6 per share. Cepheid stock was listed on the Nasdaq under the ticker symbol CPHD until it was acquired by Danaher in 2016. [35] [independent source needed] The company's first CEO was Tom Gutshall, who held the position from 1996 to 2002. [36]
For premium support please call: 800-290-4726 more ways to reach us
Image source: The Motley Fool. Abbott Laboratories (NYSE: ABT) Q4 2024 Earnings Call Jan 22, 2025, 9:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants